This document discusses Process Analytical Technology (PAT). It begins with an introduction to PAT, defining it as a system to design, analyze, and control manufacturing through timely measurements of critical quality attributes. It then discusses how PAT works by selecting a suitable PAT system and identifying critical process parameters. It highlights some key benefits of PAT such as improving process understanding and control, enhancing safety, and reducing variation. The document also provides examples of common PAT applications and discusses regulatory guidance around implementing PAT from agencies like the FDA.
Aseptic / sterile- “ A state of control attained by using an aseptic work area and performing activities in a manner that precludes microbiological contamination of the exposed sterile product”
Fluidized Bed Dryer
Principle of FBD
Construction of FBD
Working of FBD
Steps of Fluidization
Qualification of FBD
Design Qualification
Installation Qualification
Operational Qualification
Performance Qualification
References
Aseptic / sterile- “ A state of control attained by using an aseptic work area and performing activities in a manner that precludes microbiological contamination of the exposed sterile product”
Fluidized Bed Dryer
Principle of FBD
Construction of FBD
Working of FBD
Steps of Fluidization
Qualification of FBD
Design Qualification
Installation Qualification
Operational Qualification
Performance Qualification
References
Manufacturing Control Systems. J R Controls provides control systems for the manufacturing industry. A typical control system will monitor the progress of parts through the manufacturing and finishing process.
It is process of “Establishing documentary evidence that provide a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes”.
In the pharmaceutical industry, it is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results.
Validation is action of proving in accordance with the principles of good manufacturing practices, that any procedure, process, equipment, material, activity or system actually leads to expected results.
Cleaning validation is documented evidence with a high degree assurance that one can consistently clean a system or a piece of equipment to predetermined and acceptable limits.
The primary regulatory concern driving the need for cleaning validation is cross contamination of the desired drug substance either by other API from previous batch runs or by residues from the cleaning agents used.
The prime purpose of validating a cleaning process is to ensure compliance with federal and other standard regulations
1. Cross contamination with active ingredients
Contamination of one batch of product with significant levels of residual active ingredients from previous batch cannot be tolerated.
In addition to the obvious problems posed by subjecting consumers or patients to unintended contaminants, potential clinically significant synergistic interactions between pharmacologically active chemicals are a real concern.
2. Contamination with unintended materials or compounds
While inert ingredients used in drug products are generally recognized as safe for human consumption, the routine use, maintenance and cleaning of equipment's provide the potential contamination with such items as equipment parts, lubricants and chemical cleaning agents3. Microbiological contamination
Maintenance , cleaning and storage conditions may provide adventitious microorganisms with the opportunity to proliferate within the processing equipment.
What is IPQC & IPQC Test
Appearance
Drug content determination
pH
Sensitivity test
Spreadability
Rate of absorption
Extrudability
Consistency Test
Rheology & Viscosity
CONTENTS
1. General areas interest in the building:
Walls and celling's
Floors and drains
Doors ,windows and fittings
Equipment
Pipelines
2. RAW MATERIALS
3. WATER
Microbiological results
Essential document
PQ is divided into 3 phases
Microbiological procedure reviewed
4. PACKAGING MATERIALS
Process Analytical Technology (PAT) - By Kaleem PetkarKaleem Petkar
Process analytical technology (PAT) has been defined by the United States Food and Drug Administration (FDA) as a mechanism to design, analyze, and control pharmaceutical manufacturing processes through the measurement of critical process parameters (CPP) which affect the critical quality attributes (CQA).
Manufacturing Control Systems. J R Controls provides control systems for the manufacturing industry. A typical control system will monitor the progress of parts through the manufacturing and finishing process.
It is process of “Establishing documentary evidence that provide a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes”.
In the pharmaceutical industry, it is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results.
Validation is action of proving in accordance with the principles of good manufacturing practices, that any procedure, process, equipment, material, activity or system actually leads to expected results.
Cleaning validation is documented evidence with a high degree assurance that one can consistently clean a system or a piece of equipment to predetermined and acceptable limits.
The primary regulatory concern driving the need for cleaning validation is cross contamination of the desired drug substance either by other API from previous batch runs or by residues from the cleaning agents used.
The prime purpose of validating a cleaning process is to ensure compliance with federal and other standard regulations
1. Cross contamination with active ingredients
Contamination of one batch of product with significant levels of residual active ingredients from previous batch cannot be tolerated.
In addition to the obvious problems posed by subjecting consumers or patients to unintended contaminants, potential clinically significant synergistic interactions between pharmacologically active chemicals are a real concern.
2. Contamination with unintended materials or compounds
While inert ingredients used in drug products are generally recognized as safe for human consumption, the routine use, maintenance and cleaning of equipment's provide the potential contamination with such items as equipment parts, lubricants and chemical cleaning agents3. Microbiological contamination
Maintenance , cleaning and storage conditions may provide adventitious microorganisms with the opportunity to proliferate within the processing equipment.
What is IPQC & IPQC Test
Appearance
Drug content determination
pH
Sensitivity test
Spreadability
Rate of absorption
Extrudability
Consistency Test
Rheology & Viscosity
CONTENTS
1. General areas interest in the building:
Walls and celling's
Floors and drains
Doors ,windows and fittings
Equipment
Pipelines
2. RAW MATERIALS
3. WATER
Microbiological results
Essential document
PQ is divided into 3 phases
Microbiological procedure reviewed
4. PACKAGING MATERIALS
Process Analytical Technology (PAT) - By Kaleem PetkarKaleem Petkar
Process analytical technology (PAT) has been defined by the United States Food and Drug Administration (FDA) as a mechanism to design, analyze, and control pharmaceutical manufacturing processes through the measurement of critical process parameters (CPP) which affect the critical quality attributes (CQA).
PAT and QbD concepts in designing the LiMS and other Electronic systems in La...balakrishna t
tQmlab® is the premier management system for GxP operations and for supporting regulatory submissions. It delivers transformational productivity for QA/QC labs supporting customised workflows for quality control of drugs, stability testing, product release testing and post-release quality testing.
Webinar validation of pharmaceutical manufacturing processesDr. Ganesh Prasad
This is a one hour presentation on the recent concepts of pharmaceutical manufacturing process validation in line with the 2011 FDA and EMA guidelines.
Presentation: TGA manufacturing principles update - Adoption of PIC/S Guide t...TGA Australia
2018 has posed many changes for the TGA regulated Pharmaceutical manufacturing industry with the TGA legislating version 13 of the PIC/S guide to GMP for medicinal products which included several changes to both the general chapters and the relevant Annexes. With the implementation transitioning through to the end of December, Manufacturers and Sponsors need to be informed and actively implementing these changes. Additionally, a draft version of Annex 1 has also been released which has the potential to significantly impact sterile manufacturing requirements.
Master of Good Manufacturing Practice - Course Detailsutspharmacy
Staff who hold postgraduate degrees in Good Manufacturing Practice (GMP) are essential for many pharmaceutical, biologic, medical device and food manufacturing companies.
This presentation provides an overview of the Master of Good Manufacturing Practice offered at the University of Technology, Sydney (UTS) in Australia. For more information visit www.gmp.uts.edu.au
Analytical Target Profile (ATP) - Structure and Application Throughout the An...pi
ICH Q2: Validation of Analytical Procedures describes the current concepts of validation, verification and transfer of procedures. This approach addresses portions of the analytical lifecycle but also has a number of downsides. As an alternative to this approach, predefined criteria can be established in the form of an Analytical Target Profile (ATP).
Acorn Recovery: Restore IT infra within minutesIP ServerOne
Introducing Acorn Recovery as a Service, a simple, fast, and secure managed disaster recovery (DRaaS) by IP ServerOne. A DR solution that helps restore your IT infra within minutes.
Have you ever wondered how search works while visiting an e-commerce site, internal website, or searching through other types of online resources? Look no further than this informative session on the ways that taxonomies help end-users navigate the internet! Hear from taxonomists and other information professionals who have first-hand experience creating and working with taxonomies that aid in navigation, search, and discovery across a range of disciplines.
This presentation by Morris Kleiner (University of Minnesota), was made during the discussion “Competition and Regulation in Professions and Occupations” held at the Working Party No. 2 on Competition and Regulation on 10 June 2024. More papers and presentations on the topic can be found out at oe.cd/crps.
This presentation was uploaded with the author’s consent.
Sharpen existing tools or get a new toolbox? Contemporary cluster initiatives...Orkestra
UIIN Conference, Madrid, 27-29 May 2024
James Wilson, Orkestra and Deusto Business School
Emily Wise, Lund University
Madeline Smith, The Glasgow School of Art
This presentation, created by Syed Faiz ul Hassan, explores the profound influence of media on public perception and behavior. It delves into the evolution of media from oral traditions to modern digital and social media platforms. Key topics include the role of media in information propagation, socialization, crisis awareness, globalization, and education. The presentation also examines media influence through agenda setting, propaganda, and manipulative techniques used by advertisers and marketers. Furthermore, it highlights the impact of surveillance enabled by media technologies on personal behavior and preferences. Through this comprehensive overview, the presentation aims to shed light on how media shapes collective consciousness and public opinion.
0x01 - Newton's Third Law: Static vs. Dynamic AbusersOWASP Beja
f you offer a service on the web, odds are that someone will abuse it. Be it an API, a SaaS, a PaaS, or even a static website, someone somewhere will try to figure out a way to use it to their own needs. In this talk we'll compare measures that are effective against static attackers and how to battle a dynamic attacker who adapts to your counter-measures.
About the Speaker
===============
Diogo Sousa, Engineering Manager @ Canonical
An opinionated individual with an interest in cryptography and its intersection with secure software development.
0x01 - Newton's Third Law: Static vs. Dynamic Abusers
Process analytical technology
1. PRESENTED BY
ANJALI BHARAT
(M. PHARM )
QAT, ROLL NO-01
2013-2014
P.D.V.V.P.F’S COLLEGE OF PHARMACY. AHMEDNAGAR.
Process anaytical technology (pat)
2. Contents-
Introduction
Works
Types of implementation
Applications
Advantages & Disadvantages
PAT regulatory approach
References
2
3. What is PAT????
“A system for designing, analyzing & controlling
manufacturing through timely measurements (i.e.
during processing) of critical quality & performance
attributes for raw & in-process materials & processes
with the goal of ensuring final product quality.”
3
4. Principal of pat….
Quality cannot be tested
into final product; it should
be built- in, or should be by
design.
4
5. what is the goal of PAT??
Building quality into products.
To enhance understanding and control the
manufacturing process.
The goal is to reduce variation in our processes.
To enhance process safety.
5
6. HowPAT works??
Selection of Process
Selection of suitable PAT system.
Identification of CPP (critical process p)
Design Process
On-line Test In-line Test
6
7. Types of PAT Implementation
Initial phase- Process Optimization
Scale-up phase- Comparing data
Temporary process- gaining process info. &
understanding process.
Permanent process- Actual process monitoring &
control.
7
8. Why PAT Analysis is better than Lab. Analysis ??
Control environment-
Speed-
Operator error-
Safety-
Sample integrity-
8
9. Applications
Process Steps PAT Tech. in-line, off-line Testing
Raw material, Dispensing NIR, Raman
Reaction monitoring Mid- IR, N-IR, UV-visible.
Crystallization Mid-IR, Raman
API drying N-IR
Wet granulation N-IR
Fluid bed drying N-IR
Blending N-IR, Raman
Lubrication N-IR
coating N-IR
9
10. 10
Profileof a Process Analytical Scientist-
Technical-
Interpersonal effectiveness-
Initiative-
Business focus-
Innovative-
Learning
Overall leadership-
11. Advantages
Reduction in production cycle time-
Preventing reprocessing & rejection-
Increase automation-
Improve operator safety-
Reduce human error-
Improving energy & material use & increase capacity-
Continuous process-
Controlling variability-
Continuous improvement & knowledge management-
11
13. PAT regulatory approach
PAT can be implemented under CGMP
inspections by PAT team or PAT certified
investigator .
A supplement can be submitted to the agency.
A protocol can be submitted to the agency.
After approval of protocol by agency then
manufacturer may request to a FDA PAT team for
inspection of preoperational review of a PAT
implementation.
13
14. PAT regulatory guidance
Regulatory agencies like US-FDA, ICH, ASTM etc.
who has been active in the area of PAT in the
development of standards for use of PAT in
pharmaceutical industry internationally in their
standards committee E55.
US-FDA was published PAT final guidance in SEP
2004
14